NICE Endorses Brainomix 360 to Improve Stroke Treatment Access

Brainomix, a leading provider of artificial intelligence (AI)-enabled software, has received guidance from the National Institute of Health and Care Excellence (NICE) to support the use of their software, Brainomix 360, in clinical decision-making for strokes. This endorsement by NICE aims to expedite access to effective treatment for stroke patients.

A stroke is a life-threatening medical condition that occurs when there is a disruption in the blood supply to parts of the brain. It is responsible for over 100,000 cases in the UK each year. Brainomix 360, formerly known as e-Stroke, was selected as one of two AI software solutions by the health technology assessment agency, providing evidence of better and faster access to treatment.

The recent guidance from NICE enables the NHS to utilize Brainomix 360 while further evidence is gathered to determine its cost-effectiveness. Implementation of this software has shown significant improvements in treatment access and outcomes for patients with suspected strokes. The Health Technology Assessment demonstrated that patients admitted with suspected strokes had expedited access to treatment following the implementation of Brainomix 360.

Dr. Michalis Papadakis, co-founder and CEO of Brainomix, expressed his excitement about this recommendation and highlighted the real-world evidence that has demonstrated the transformative impact of Brainomix 360 on stroke treatment. The average thrombectomy treatment rate in hospitals using Brainomix 360 was found to be 55% higher than the national average, according to a report from Health Innovation Oxford and Thames Valley.

With its widespread adoption across England and deployment in over 30 countries, including national-level usage in Wales and Hungary, Brainomix 360 is now entering the US market following clearance by the US Food and Drug Administration. This software has the potential to revolutionize stroke treatment globally by assisting clinicians in making more confident decisions and ensuring more patients gain access to life-saving treatments.

NICE’s endorsement of Brainomix 360 marks a significant step forward in improving stroke treatment access and outcomes. As further evidence is collected to assess its cost-effectiveness, this AI-enabled software has the potential to transform the way strokes are diagnosed and treated, ultimately saving more lives.

FAQ Section:

1. What is Brainomix 360?
– Brainomix 360 is an AI-enabled software developed by Brainomix, a leading provider of artificial intelligence software. It is designed to support clinical decision-making for strokes.

2. How has Brainomix 360 received guidance and support?
– Brainomix 360 has received guidance from the National Institute of Health and Care Excellence (NICE). This endorsement aims to expedite access to effective treatment for stroke patients.

3. What is a stroke?
– A stroke is a life-threatening medical condition that occurs when there is a disruption in the blood supply to parts of the brain.

4. How many cases of stroke occur in the UK each year?
– Over 100,000 cases of stroke occur in the UK each year.

5. How has Brainomix 360 improved treatment access and outcomes?
– Implementation of Brainomix 360 has shown significant improvements in treatment access and outcomes for patients with suspected strokes. Patients admitted with suspected strokes had expedited access to treatment following the implementation of Brainomix 360.

6. What evidence supports the effectiveness of Brainomix 360?
– A report from Health Innovation Oxford and Thames Valley found that hospitals using Brainomix 360 had an average thrombectomy treatment rate 55% higher than the national average.

7. How widely is Brainomix 360 used?
– Brainomix 360 has been widely adopted across England and has been deployed in over 30 countries, including national-level usage in Wales and Hungary. It is now entering the US market after clearance by the US Food and Drug Administration.

8. How can Brainomix 360 revolutionize stroke treatment globally?
– Brainomix 360 has the potential to revolutionize stroke treatment globally by assisting clinicians in making more confident decisions and ensuring more patients gain access to life-saving treatments.

Definitions:

– National Institute of Health and Care Excellence (NICE): NICE is a health technology assessment agency in the UK that provides guidance and recommendations on the use of healthcare technologies and interventions.

– Thrombectomy: Thrombectomy is a surgical procedure to remove a blood clot from a blood vessel.

– AI-enabled software: AI-enabled software refers to software that incorporates artificial intelligence capabilities, allowing it to perform tasks and make decisions typically associated with human intelligence.

Suggested Related Links:

Brainomix (Main domain of Brainomix)
NICE (National Institute of Health and Care Excellence)